Tracking hormones through perimenopause
Perimenopause is diagnosed from your symptoms and your cycle pattern, not from a blood test. Hormones in the years before menopause do not decline in a tidy line — they become erratic, and a single panel can catch a high day, a low day, or a day that looks entirely ordinary. That is not a flaw in the testing. It is the actual physiology.
Bloodwork is still worth doing in this period. It is just worth doing for the right reasons, at the right point in your cycle, and with realistic expectations about what one panel settles.
Key takeaways
Perimenopause is a clinical diagnosis. Blood tests support the picture rather than confirm it.
Variability is the signal. Erratic results are characteristic, not contradictory.
Cycle timing changes what a result means, so the day matters as much as the number.
FSH and AMH answer narrow questions and are frequently over-interpreted.
The markers that shift alongside — iron, thyroid, lipids, glucose, bone — are often the more actionable ones.
What actually changes, and in what order?
The sequence is more useful to understand than any individual value. Ovulation becomes less consistent first, and because progesterone is produced after ovulation, luteal progesterone falls away earliest and most noticeably. Oestradiol does not simply decline: for several years it swings, often reaching higher peaks than before as well as lower troughs, which is why symptoms can include both oestrogen-excess and oestrogen-deficiency patterns in the same person within a few months.
FSH rises as the ovaries become less responsive, but it rises unevenly, and a single high reading followed by a normal one is entirely typical. Testosterone declines gradually with age rather than sharply at menopause. SHBG shifts with oestrogen, thyroid status and metabolic health, which changes how much of what is measured is actually available.
Which markers are worth measuring?
Marker | What it answers | What it will not answer |
|---|---|---|
FSH | Whether the ovaries are being pushed harder | Whether you are in perimenopause. Fluctuates too much for a single value to settle it. |
Oestradiol | Where oestrogen sits on that specific day | Your average. Peaks and troughs both look like data points. |
Progesterone | Whether you ovulated in this cycle, when drawn mid-luteal | Anything useful if drawn at the wrong point in the cycle. |
AMH | Ovarian reserve, mainly relevant to fertility planning | When menopause will happen, or how you will feel. |
LH | Context alongside FSH | Much on its own outside specific clinical questions. |
Testosterone and SHBG | Circulating androgen and how much is bound | Symptom causation, which is rarely a single-hormone story. |
TSH, free T4, free T3 | Whether thyroid explains overlapping symptoms | Nothing about hormones directly, but it rules a lot in or out. |
Ferritin and full blood count | Whether heavier cycles have depleted iron | Very often the most actionable result on the whole panel. |
HbA1c, lipids, blood pressure | Cardiometabolic direction of travel through the transition | Immediate symptoms, though the long-run relevance is high. |
When in your cycle should you test?
If you are still cycling with any regularity, timing changes the interpretation completely:
Day two to five of your cycle, counting the first day of full flow as day one, is the conventional window for FSH, LH and oestradiol. It is the point at which those values are most comparable between cycles and between people.
Mid-luteal, roughly seven days after ovulation — often around day 19 to 21 in a 28-day cycle, but earlier or later if your cycle is shorter or longer — is when progesterone is worth measuring, because that is when it peaks if ovulation occurred.
Any day is fine for thyroid, iron, glucose, lipids and the general panel. Those are not cycle-dependent in any meaningful way.
If cycles have become irregular enough that timing is guesswork, that irregularity is itself more informative than the hormone value would be. Record the pattern rather than chasing the perfect draw day.
Why does one snapshot mislead?
Because you are sampling a system whose defining feature during this period is variability. Two panels taken six weeks apart can look like they belong to different people, and both can be accurate. A normal FSH does not exclude perimenopause, and a single raised FSH does not confirm menopause — the standard clinical definition of menopause is twelve consecutive months without a period, arrived at retrospectively, not from a blood result.
This is the general problem with single readings, drawn sharply: a panel is a snapshot of a moving system, and here the system is moving faster than usual.
What is worth tracking besides bloodwork?
A written record over a few months carries more diagnostic weight than any single panel. Worth logging: cycle length and flow, and how both are changing; sleep quality and night waking; temperature symptoms and their timing; mood and cognitive changes and where they fall in the cycle; joint aches; and energy patterns.
Keep it alongside your results rather than separately. The pattern that emerges from three months of notes plus two panels is what a clinician can actually act on. A single result with no context is what generates another test.
What often gets missed?
Two things, repeatedly. The first is iron. Heavier and less predictable bleeding is one of the most common features of early perimenopause, and it quietly depletes stores over months. Fatigue then gets attributed to hormones when iron studies would have shown something correctable.
The second is thyroid. Thyroid disorders become more common with age, and the symptom overlap with perimenopause is close to total — fatigue, weight change, mood change, temperature intolerance, brain fog. It is worth reading a full thyroid panel before concluding that hormones explain everything. Bone health and cardiometabolic markers also deserve attention through this window, since the transition is when the trajectory of both tends to change.
Frequently asked questions
Can a blood test tell me if I am in perimenopause?
Not reliably on its own. Perimenopause is diagnosed from symptoms and cycle changes, with bloodwork used to support the picture and to exclude other explanations such as thyroid disease or iron deficiency.
What does a high FSH mean?
It suggests the ovaries are being stimulated harder to produce the same output. Because FSH fluctuates considerably during perimenopause, one high reading is not confirmation of anything, and a normal reading does not exclude the transition.
When should progesterone be tested?
Mid-luteal phase, about seven days after ovulation, which is when it peaks if you ovulated. Drawn at any other point it will be low regardless, and that low result means nothing.
Is AMH useful for predicting menopause?
AMH is primarily a fertility marker reflecting ovarian reserve. It correlates loosely with timing at a population level but is not accurate enough to predict when an individual will reach menopause.
Should I retest hormones, and how often?
Repeat testing is most useful when it is answering a specific question rather than tracking a moving target. For general monitoring, an annual panel that includes thyroid, iron and metabolic markers is usually more informative than frequent hormone draws.
Reading the whole picture
Hormones are the part of this period that gets the attention, and the part that a single panel handles worst. A DearLife 360 reads your hormone results alongside thyroid, iron, metabolic and inflammatory markers, bands what it finds, and writes out the questions worth taking to your doctor. If you need a comprehensive panel arranged first, that can be organised for you.